Xcout Intel
Gero competitors & alternatives
The 12 closest competitors and alternatives to Gero among drug discovery companies — ranked by similarity to what Gero actually does, not by market-cap band.
Subscribe to see Gero’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Gero
Gero is a biotechnology company headquartered in Singapore with a U.S. subsidiary, combining physics, biology, and artificial intelligence to decode human biology and develop life-changing medicines.
Gero at a glance
Gero is a drug discovery company headquartered in Singapore. It has raised at least $23M across the 2 funding rounds on record. Its most recent funding round, Series A extension, raised $17M in June 2026. Xcout tracks 6 named people at Gero, including Aleksandr Sviridov (Chief Operating Officer).
Gero leadership
- Aleksandr SviridovChief Operating Officer
- Peter Fedichevco-founder and CEO
- Max KholinCo-founder, Chief Corporate Development Officer
- Maxim Kholinco-founder
- Brian KennedyIndependent Director
- Yuri MelnichekBoard Member
Gero funding rounds
At least $23M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A extension | $17M | 3 named | |
| Series A | $6M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Gero competitors
Ranked by semantic similarity — how close each company is to Gero by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar drug discovery company
Generare is a biotechnology and artificial intelligence company headquartered in Paris, France, focused on commercial bioprospecting and decoding natural products.
Similar drug discovery company
Cassidy Bio is an AI-first biotechnology company founded in 2024 and based in Israel that is developing a programmable platform for gene editing. The company utilizes a genomic foundation model powered by artificial intelligence to design safer and more scalable gene editing therapies across various guides, editors, and delivery contexts.
Similar drug discovery company
Automera is an early-stage biotechnology research company headquartered in Singapore. The company focuses on the development of novel therapeutics through autophagy-based targeted protein degradation.
Similar drug discovery company
Ochre Bio is a biotechnology company developing precision medicines for chronic liver diseases. It uses data from human donor livers, computational biology, and experimental models to identify and validate therapeutic targets for pharmaceutical and biotechnology development.
Similar drug discovery company
QurieGen is a precision medicine company headquartered in Nijmegen, Netherlands, that uses single-cell AI to transform drug development and create treatments more efficiently.
Similar drug discovery company
Retro Biosciences is a biotechnology research company based in Redwood City, California, that develops therapies targeting aging biology. Its goal is to extend healthy human lifespan by 10 years.
Similar drug discovery company
Lighthouse Pharma is a clinical-stage private biopharmaceutical company that specializes in precision medicine approaches targeting major unmet medical needs. The company is headquartered at the Buck Institute for Research on Aging in California.
Similar drug discovery company
Albatroz Therapeutics is a pre-clinical stage biotechnology company based in Singapore that is developing first-in-class antibody therapeutics to protect the extracellular matrix and treat solid tumors.
Deeptech
Atinary is an artificial intelligence company with operations in Silicon Valley and Switzerland, featuring headquarters in Menlo Park, California. The company provides a code-free AI platform that accelerates research, development, and discovery in molecular science and chemistry.
Biopharmaceuticals
George Medicines is an independent spin-out company from The George Institute for Global Health, headquartered in London, England, focused on developing innovative treatments for the leading causes of death and managing non-communicable diseases.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Gero and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Geroand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →